Von Willebrand factor: Molecular size and functional activity

Annals of Hematology

Volumn 72, Issue 6, 1996, Pages 341-348

  Furlan, M ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Binding affinity; Multimers; Phenotype; Von Willebrand disease; Von Willebrand factor

Indexed keywords

COLLAGEN; ENZYME; GLYCOPROTEIN; PLASMA PROTEIN; PROTEIN SUBUNIT; PROTEINASE; THROMBOCYTE RECEPTOR; VON WILLEBRAND FACTOR;

BINDING SITE; BLEEDING TENDENCY; BLOOD VESSEL INJURY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PURIFICATION; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN CELL; MOLECULAR SIZE; MYELOPROLIFERATIVE DISORDER; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SUBENDOTHELIUM; THROMBOCYTE ADHESION; THROMBOCYTE MEMBRANE; THROMBOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; VON WILLEBRAND DISEASE;

BLOOD PLATELETS; COLLAGEN; GENOTYPE; HUMANS; PEPTIDE HYDROLASES; PHENOTYPE; STRUCTURE-ACTIVITY RELATIONSHIP; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 0029907370     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050184     Document Type: Review

References (52)

1. Ruggeri ZM, Ware J (1993) von Willebrand factor. FASEB J 7:308-316
2. Meyer D, Girma J-P (1993) von Willebrand factor: structure and function. Thromb Haemost 70:99-104
3. Montgomery RR, Coller BS (1994) Von Willebrand disease. In: Colman RW, Hirsh J, Marder VJ, Salzman EW (eds) Haemostasis and thrombosis: basic principles and clinical practice, 3rd edn. Lippincott, Philadelphia, pp 134-168
4. Ruggeri ZM (1994) Pathogenesis and classification of von Willebrand disease. Haemostasis 24:265-275
5. Pareti FI, Fujimura Y, Dent JA, Holland LZ, Zimmerman TS, Ruggeri ZM (1986) Isolation and characterization of a collagen binding domain in human von Willebrand factor. J Biol Chem 261:15310-15315
6. Kalafatis M, Takahashi Y, Girma J-P, Meyer D (1987) Localization of a collagen-interactive domain of human von Willebrand factor between amino acid residues Gly 911 and Glu 1365. Blood 70:1577-1583
7. Pareti FI, Niiya K, McPherson M, Ruggeri ZM (1987) Isolation and characterization of two domains of human von Willebrand factor that interact with fibrillar collagen types I and III. J Biol Chem 262:13835-13841
8. Cruz MA, Yuan H, Lee JR, Wise RJ, Handin RL (1995) Interaction of the von Willebrand factor (vWF) with collagen. Localization of the primary collagen-binding site by analysis of recombinant vWF A domain polypeptides. J Biol Chem 270:10822-10827
9. Mohri H, Fujimura Y, Shima M, Yoshioka A, Houghten RA, Ruggeri ZM, Zimmerman TS (1988) Structure of the von Willebrand factor domain interacting with glycoprotein Ib. J Biol Chem 263:17901-17904
10. Berndt MC, Ward CM, Booth WJ, Castaldi PA, Mazurov AV, Andrews RK (1992) Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence in von Willebrand factor. Mechanism of modulation of von Willebrand factor by ristocetin and botrocetin. Biochemistry 31:11144-11151
11. Cruz MA, Handin RI, Wise RJ (1993) The interaction of the von Willebrand factor-Al domain with platelet glycoprotein Ib/IX. The role of glycosylation and disulfide bonding in a monomeric recombinant A1 domain protein. J Biol Chem 268:21238-21245
12. Matsushita T, Sadler JE (1995) Identification of amino acid residues essential for von Willebrand factor binding to platelet glycoprotein Ib. Charged-to-alanine scanning mutagenesis of the A1 domain of human von Willebrand factor. J Biol Chem 270:13406-13414
13. de Groot PG, Ottenhof-Rovers M, van Mourik JA, Sixma JJ (1988) Evidence that primary binding site of von Willebrand factor that mediates platelet adhesion on subendothelium is not collagen. J Clin Invest 82:65-73
14. Furlan M, Stieger J, Beck EA (1987) Exposure of platelet binding sites in von Willebrand factor by adsorption onto polystyrene latex particles. Biochim Biophys Acta 924:27-37
15. Olson JD, Zaleski A, Herrmann D, Flood PA (1989) Adhesion of platelets to purified solid-phase von Willebrand factor: effects of wall shear rate, ADP, thrombin, and ristocetin. J Lab Clin Med 14:6-18
16. Peterson DM, Stathopoulos NA, Giorgio TD, Hellums JD, Moake JL (1987) Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa. Blood 69:625-628
17. Howard MA, Firkin BG (1971) Ristocetin - a new tool in the investigation of platelet aggregation. Thromb Haemost 26:362-369
18. De Marco L, Girolami A, Russel S, Ruggeri ZM (1985) Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation. J Clin Invest 75:1198-1203
19. Read MS, Shermer RW, Brinkhous KM (1978) Venom coagglutinin: an activator of platelet aggregation dependent on von Willebrand factor. Proc Natl Acad Sci USA 75:4514-4518
20. 728. Blood 70:985-988
21. Ikeda Y, Handa M, Kawano K, Kamata T, Murata M, Araki Y, Anbo H, Kawai Y, Watanabe K, Itagaki I, Sakai K, Ruggeri ZM (1991) The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest 87:1234-1240
22. Chow TW, Hellums JD, Moake JI, Kroll NM (1992) Shear stress-induced von Willebrand factor binding to platelet glycoprotein Ib initiates calcium influx associated with aggregation. Blood 80:113-120
23. 3) mediated by fibrinogen and glycoprotein Ib-von Willebrand factor. J Biol Chem 267:11300-11306
24. Fowler WE, Fretto LJ, Hamilton KK, Erickson BP, McKee PA (1985) Substructure of human von Willebrand factor. J Clin Invest 76:1491-1500
25. Counts RB, Paskell SL, Elgee SK (1978) Disulfide bonds and the quaternary structure of factor VIII/von Willebrand factor. J Clin Invest 62:702-709
26. Perret BA, Furlan M, Beck EA (1979) Studies on factor VIII-related protein. II. Estimation of molecular size differences between factor VIII oligomers. Biochim Biophys Acta 578:164-174
27. Wagner DD, Lawrence SO, Ohlsson-Wilhelm BM, Fay PJ, Marder VJ (1987) Topology and order of formation of inter-chain disulfide bonds in von Willebrand factor. Blood 69:27-32
28. Furlan M, Perret BA, Beck EA (1979) Studies on factor VIII-related protein. III. Size distribution and carbohydrate content of human and bovine factor VIII. Biochim Biophys Acta 579:325-333
29. Furlan M, Perret BA, Beck EA (1981) Von Willebrand activity of low-molecular-weight human factor VIII increases by binding to gold granules. Thromb Haemost 45:242-246
30. Federici AB, Bader R, Pagani S, Colibretti ML, De Marco L, Mannucci PM (1989) Binding of von Willebrand factor to glycoproteins Ib and IIb/IIIa complex: affinity is related to multimeric size. Br J Haematol 73:93-99
31. Morisato DK, Gralnick HR (1980) Selective binding of the factor VIII/von Willebrand factor protein to human platelets. Blood 55:9-15
32. Berndt MC, Gregory C, Kabral A, Zola H, Fournier D, Castaldi PA (1985) Purification and preliminary characterization of the glycoprotein Ib complex in the human platelet membrane. Eur J Biochem 151:637-649
33. White JG, Krumwiede MD, Cocking-Johnson DJ, Escolar G (1995) Dynamic redistribution of glycoprotein Ib/IX on surface-activated platelets. A second look. Am J Pathol 147:1057-1067
34. Tsai H-M, Nagel RL, Hatchee VB, Sussman II (1989) Multimeric composition of endothelial cell-derived von Willebrand factor. Blood 73:2074-2076
35. Chopek MW, Girma J-P. Fujikawa K, Davie EW, Titani K (1986) Human von Willebrand factor: a multivalent protein composed of identical subunits. Biochemistry 25:3146-3155
36. Dent JA, Galbusera M, Ruggeri ZM (1991) Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit. J Clin Invest 88:774-782
37. Furlan M, Robles R, Affolter D, Meyer D, Baillod P, Lämmle B (1993) Triplet structure of von Willebrand factor reflects proteolytic degradation of high molecular weight multimers. Proc Natl Acad Sci USA 90:7503-7507
38. Dent JA, Berkowitz SD, Ware J, Kasper CK, Ruggeri ZM (1990) Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor. Proc Natl Acad Sci USA 87:6306-6310
39. Zimmerman TS, Dent JA, Ruggeri ZM, Nannini LH (1986) Subunit composition of plasma von Willebrand factor. Cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers (types IIC, IID, and IIE). J Clin Invest 77:947-951
40. Levene RB, Booyse FM, Chediak J, Zimmerman TS, Livingston DM, Lynch DC (1987) Expression of abnormal von Willebrand factor by endothelial cells from a patient with type IIA von Willebrand disease. Proc Natl Acad Sci USA 84:6550-6554
41. Budde U, Dent JA, Berkowitz SD, Ruggeri ZM, Zimmerman TS (1986) Subunit composition of plasma von Willebrand factor in patients with myeloproliferalive syndrome. Blood 68:1213-1217
42. Moake JL, Rudy CK, Troll JH, Weinstein MJ, Colannino NM, Azocar J, Seder RH, Hong SL, Deykin D (1982) Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 307:1432-1435
43. Furlan M, Robles R, Lämmle B (1995) Purification and characterization of a protease from human plasma, cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Thromb Haemost 73:1158 (abstract)
44. Chang H-Y, Chen Y-P, Chediak JB, Levene RB, Lynch DC (1989) Molecular analysis of von Willebrand factor produced by endothelial cell strains from patients with type IIA von Willebrand disease. Blood 74 [Suppl 1]:131a (abstract)
45. Lyons SE, Bruck ME, Bowie EJW, Ginsburg D (1992) Impaired intracellular transport produced by a subset of type IIA von Willebrand disease. J Biol Chem 267:4424-4430
46. Lyons SE, Cooney KA, Bockenstedt P, Ginsburg D (1994) Characterization of Leu777Pro and Ile865Thr type IIA von Willebrand disease mutations. Blood 83:1551-1557
47. Ginsburg D, Sadler JE (1983) Von Willebrand disease: a database of point mutations, insertions, and deletions. Thromb Haemost 69:177-184
48. Ruggeri ZM, Pareti PM, Mannucci PM, Ciavarella N, Zimmermann TS (1980) Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease. N Engl J Med 302:1047-1051
49. Sadler JE (1994) A revised classification of von Willebrand disease. Thromb Haemost 71:520-525
50. Sadler JE, Matsushita T, Dong Z, Tuley EA, Westfield LA (1995) Molecular mechanism and classification of von Willebrand disease. Thromb Haemost 74:161-166
51. Ørstavik KH, Kornstad L, Reisner H, Berg K (1989) Possible effect of secretor locus on plasma concentration of factor VIII and von Willebrand factor. Blood 73:990-993
52. Green D, Jarrett O, Ruth KJ, Folsom AR, Liu K (1995) Relationship among Lewis phenotype, clotting factors, and other cardiovascular risk factors in young adults. J Lab Clin Med 125:334-339